{"a": [["Effect of exogenous oestrogen on carbohydrate metabolism in post menopausal women", "1972"], ["Hormone replacement therapy in post menopausal women with diabetes mellitus: a risk benefit assessment", "2000"], ["Breast cancer and hormone replacement therapy in the million women study", "2003"], ["Effect of 17 beta\u2010estradiol on plasma lipids and LDL oxidation in post\u2010menopausal women with type 2 diabetes mellitus", "1997"], ["Effects of low doses of transdermal 17\u2010estradiol on carbohydrate metabolism in post menopausal women", "1992"], ["Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National and Nutritional Surbey (NHANES III)", "2002"], ["Hormone replacement therapy with dydrogesterone and 17b oestradiol: effects of serum lipoproteins and glucose tolerance during 24 months follow up", "1997"], ["Estrogen plus progestin and risk of venous thrombosis", "2004"], ["Pregnancy and insulin resistance", "2006"], ["The effect of intensive treatment of diabetes on the development and progression of long\u2010term complications in insulin\u2010dependent diabetes mellitus", "1993"], ["Research Strategy", "2006"], ["Menopause in type 1 diabetic women: is it premature?", "2001"], ["Hormone replacement therapy is associated with better glycaemic control in women with type 2 diabetes: the Northern California Kaiser Permanente Diabetes Registry", "2001"], ["Symptoms associated with menopausal transition and reproductive hormones in mid life women", "2007"], ["Quantifying heterogeneity in a meta\u2010analysis", "2002"], ["Measuring inconsistency in meta\u2010analysis", "2003"], ["Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011", "2011"], ["Noncardiovascular disease outcomes during the 6.8 years of hormone therapy", "2002"], ["HRT in the early menopause: scientific evidence and common perceptions", "2008"], ["Diabetes and the menopause", "2005"], ["Mortality and hormone\u2010related exposure in women with diabetes", "1999"], ["The case of the misleading funnel plot", "2006"], ["The PRISMA statement for reporting systematic and meta\u2010analyses of studies that evaluate interventions: explanation and elaboration", "1999"], ["A possible bimodal effect of oestrogen on insulin sensitivity in post menopausal women and the attenuating effect of added progestin", "1993"], ["Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes", "2004"], ["Ovarian cancer and HRT in the million women study", "2007"], ["Effectiveness of self\u2010management training in type 2 diabetes: a systematic review of randomised control trials", "2001"], ["General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy", "2001"], ["Can postmenopausal hormone replacement improve plasma lipids in women with diabetes? The atherosclerosis risk in communities study investigators", "1996"], ["Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause", "2007"], ["Psychosocial barriers to diabetes self\u2010management and quality of life", "2001"], ["Hormone replacement therapy and cardiovascular risk in post menopausal women with NIDDM", "1996"], ["Self care in diabetes: models of factors affecting self care", "2005"], ["Hormone replacement therapy, cardiovascular risk factors and diabetes", "2000"], ["Recommendations for examining and interpreting funnel plot asymmetry in meta\u2010analyses of randomised controlled trials", "2011"], ["Middle\u2010aged premenopausal women with type 1 diabetes have lower bone mineral density and calcaneal quantitative ultrasound than nondiabetic women", "2006"], ["Psychosocial and quality of life correlates of glycaemic control during intensive treatment of type 1 diabetes", "2001"], ["Health related quality of life after combined hormone replacement therapy: randomised control trial: one year's results of the women's international study of long duration oestrogen after menopause (WISDOM) trial", "2008"], ["Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principle results from the women's health initiative randomized control trial", "2002"], ["Reproductive disturbances in type 1 diabetic women", "2005"]], "ex": [["Urinary tract infections in post menopausal women: effect of hormone therapy and risk factors", "2001"], ["Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women", "2001"], ["Glycaemic effects of postmenopausal hormone therapy: the heart and estrogen/progestin replacement therapy", "2003"]], "in": [["Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes", "2004"]]}